Evidence map›Paper›PMID 36865667›Full record

ArticleGlobal journal of orthopedics research2023

Long Duration Sonophoresis of Diclofenac to Augment Rehabilitation of Common Musculoskeletal Injuries.

Paddy Jarit, Dominic Klyve, Rod Walters

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Global journal of orthopedics research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05254470 (Customer Survey of Athletic Trainers Who Utilize SAM Ultrasound Device in Routine Care), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05254470 completednot on this map

Customer Survey of Athletic Trainers Who Utilize SAM Ultrasound Device in Routine Care

TypeobservationalSponsorZetrOZ, Inc.Ran2020 to 2022Enrolled135ConditionsMusculoskeletal Injury, Pain, Chronic, Pain, Acute, Sport InjuryArmsContinuous Ultrasound
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Long Duration Continuous Ultrasound with Diclofenac Sodium Enhances Recovery from Sprains and Strains.International journal on physical medication & rehabilitation · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Paddy JaritDepartment of Sport & Orthopaedic Physical Therapy, Fairfield, CT, USA.
Dominic KlyveDepartment of Mathematics, Central Washington University, Ellensburg, WI, USA.
Rod WaltersConsultants in Sports Medicine, Columbia, SC, USA.
Central Washington University · US

Funding

Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee OsteoarthritisR44AG061985 · NIA · ZETROZ SYSTEMS, LLC · PI George Kenneth Lewis · 2020 to 2026
$11.0M
Daily and localized NSAID sonophoresis for symptomatic treatment of knee osteoarthritisR43AG061985 · NIA · ZETROZ SYSTEMS, LLC · PI LEWIS, GEORGE KENNETH · 2018 to 2019
$448k
NIA NIH HHS R43 AG061985NIA NIH HHS R44 AG061985
6 · The paper itself

Abstract

Background: The use of long duration sonophoresis (LDS) for musculoskeletal injuries is a new and emerging treatment option for patients undergoing rehabilitation. The treatment is non-invasive, provides multi-hour mechanical stimulus expediating tissue regeneration and deep tissue heat along with local application of therapeutic compound for improved pain relief. The objective of this prospective case study was to evaluate real-world application of diclofenac LDS as an add-on intervention for patients non-responsive to physical therapy alone. Methods: Patient who failed to respond to at least 4 weeks of physical therapy were treated with the addition of 2.5% diclofenac LDS daily for 4 weeks. The numerical rating scale, global health improvement score, functional improvement, and treatment satisfaction index were measured to assess pain reduction and quality of life improvement from treatment. Patient outcome data was organized by injury type and patient age groups, and statistically analyzed with ANOVA to assess treatment differences within and between groups. The study was registered on clinicaltrails.gov NCT05254470. Result: The study included (n=135) musculoskeletal injury LDS treatments with no adverse events. Patients reported a mean pain reduction from baseline of 4.44 points (p<0.0001) and a 4.85point health improvement score after 4-week of daily sonophoresis treatment. There were no age-related differences in pain reduction, and 97.8% of patients in the study reported functional improvement with the addition of LDS treatment. Significant pain relief was observed in injuries related to tendinopathy, sprain, strain, contusion, bone fracture, and post-surgical recovery. Conclusion: The use of LDS significantly reduced pain and improved musculoskeletal function and quality of life for patients. Clinical findings suggest that LDS with 2.5% diclofenac is a viable therapeutic option for practitioners and should be further investigated.

Indexed as

Continuous ultrasoundLong duration sonophoresisLow-intensity continuous ultrasoundMusculoskeletal injuriesPain managementPhonophoresisRehabilitation

Identifiers

PMID36865667
PMCPMC9977165
OpenAlexW4323035083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.